Initial biocompatibility and enhanced osteoblast response of Si doping in a porous BCP bone graft substitute

Journal of Materials Science: Materials in Medicine

Volumn 21, Issue 6, 2010, Pages 1937-1947

  Byun, In Seon ^a   Sarkar, Swapan Kumar ^a   Anirban Jyoti, M ^a   Min, Young Ki ^a   Seo, Hyung Seok ^b   Lee, Byong Taek ^a   Song, Ho Yeon ^a  

^a Soonchunhyang University   (South Korea)

^b Konyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZARIN RED; BIPHASIC CALCIUM PHOSPHATES; BONE GRAFT; BONE GRAFT SUBSTITUTES; BONE SUBSTITUTES; CELLULAR ADHESION; CELLULAR CYTOTOXICITY; CELLULAR DIFFERENTIATION; CELLULAR RESPONSE; CELLULAR VIABILITY; COLLAGEN TYPE I; GRANULAR SHAPE; LATE STAGE; MTT ASSAYS; OSTEOBLAST RESPONSE; OSTEOPONTIN; SI-DOPING; TIME POINTS;

ADHESION; BIOCOMPATIBILITY; BONE; CALCIUM; CALCIUM PHOSPHATE; CELL PROLIFERATION; GRAFTS; GRANULATION; SEMICONDUCTOR DOPING; SILICON;

GENE EXPRESSION;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BIPHASIC CALCIUM PHOSPHATE; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; MESSENGER RNA; OSTEONECTIN; OSTEOPONTIN; SILICON; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BONE GRAFT; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SPREADING; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DOPING; FILOPODIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN TYPE I; GENE EXPRESSION; HUMANS; MICE; OSTEOBLASTS; OSTEONECTIN; OSTEOPONTIN; POROSITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77954540149     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-010-4061-1     Document Type: Article

References (50)

1. LL Hench 1998 Biomaterials: a forecast for the future Biomaterials 19 1419 1423 10.1016/S0142-9612(98)00133-1 1:CAS:528:DyaK1cXms1KgtrY%3D 9794512 (Pubitemid 28470667)
2. H Oonishi 1991 Orthopaedic applications of hydroxyapatite Biomaterials 12 171 178 10.1016/0142-9612(91)90196-H 1:STN:280:DyaK3Mzks1ejtA%3D%3D 1652293
3. S Yang K-F Leong Z Du C-K Chua 2001 The design of scaffolds for use in tissue engineering. Part I. Traditional factors Tissue Eng 7 679 689 10.1089/107632701753337645 1:STN:280:DC%2BD38%2FgsVOisA%3D%3D 11749726 (Pubitemid 34042301)
4. T-MG Chu DG Orton SJ Hollister SE Feinberg JW Halloran 2002 Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures Biomaterials 23 1283 1293 10.1016/S0142-9612(01)00243-5 1:CAS:528: DC%2BD38XovFWksg%3D%3D 11808536 (Pubitemid 34112425)
5. M Mastrogiacoma A Muraglia V Komlev F Peryin F Rustichelli A Crovace, et al. 2005 Tissue engineering of bone: search for a better scaffold Orthodont Craniofac Res 8 277 284 10.1111/j.1601-6343.2005.00350.x
6. SV Dorozhkin M Epple 2002 Biological and medical significance of calcium phosphates Angew Chem Int Ed 41 3130 3146 10.1002/1521-3773(20020902)41: 17<3130::AID-ANIE3130>3.0.CO;2-1 1:CAS:528:DC%2BD38XntFWkur4%3D (Pubitemid 35021275)
7. P Buma PJM Van Loon H Versleyen H Weinans TJJH Slooff K De Groot R Huiskes 1997 Histological and biomechanical analysis of bone and interface reactions around hydroxyapatite-coated intramedullary implants of different stiffness: a pilot study on the goat Biomaterials 18 1251 1260 10.1016/S0142-9612(97)00064-1 1:CAS:528:DyaK2sXls1KhsLg%3D 9300560 (Pubitemid 27390304)
8. P Van Landuyt F Li JP Keustermans JM Streydio F Delannay E Munting 1995 The influence of high sintering temperatures on the mechanical properties of hydroxylapatite J Mater Sci: Mater Med 6 8 13 10.1007/BF00121239
9. U Ripamonti 1996 Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models Biomaterials 17 31 35 10.1016/0142-9612(96)80752-6 1:CAS:528:DyaK28XhvFyjtA%3D%3D 8962945
10. O Gauthier E Goyenvalle JM Bouler J Guicheus P Pilet P Weiss G Daculsi 2001 Macroporous biphasic calcium phosphate ceramics versus injectable bone substitute: a comparative study 3 and 8 weeks after implantation in rabbit bone J Mater Sci: Mater Med 12 385 390 10.1023/A:1011284517429 1:CAS:528: DC%2BD3MXktlSkt7c%3D (Pubitemid 32488113)
11. H Yuan Z Yang JD Bruijn K Groot X Zhang 2001 Material-dependent bone induction by calcium phosphate ceramics: a 2.5-year study in dog Biomaterials 22 2617 2623 10.1016/S0142-9612(00)00450-6 1:CAS:528:DC%2BD3MXlsFymu7c%3D 11519781 (Pubitemid 32727836)
12. A Piattelli A Scarano C Mangano 1996 Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement Biomaterials 17 1767 1770 10.1016/0142-9612(95)00342-8 1:CAS:528:DyaK28Xls1Omtr4%3D 8879514 (Pubitemid 26355419)
13. G Daculsi 1998 Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute Biomaterials 19 1473 1478 10.1016/S0142-9612(98)00061-1 1:CAS:528:DyaK1cXms1Klt7s%3D 9794521 (Pubitemid 28470675)
14. Elliot J. Structure and chemistry of the apatites and other calcium orthophosphates. New York: Elsevier; 1994.
15. IR Gibson SM Best W Bonfield 1999 Chemical characterization of silicon-substituted hydroxyapatite J Biomed Mater Res 44 422 428 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-# 1:CAS:528:DyaK1MXlslKmtg%3D%3D 10397946 (Pubitemid 29031125)
16. EM Carlisle 1970 Silicon: a possible factor in bone calcification Science 167 279 280 10.1126/science.167.3916.279 1:CAS:528:DyaE3cXns1KqsQ%3D%3D 5410261 1970Sci...167..279C
17. EM Carlisle 1980 A silicon requirement for normal skull formation in chicks J Nutr 110 2 352 359 1:CAS:528:DyaL3cXhsVGgtr8%3D 7354405
18. EM Carlisle 1980 Biochemical and morphological changes associated with long bone abnormalities in silicon deficiency J Nutr 110 1046 1056 1:CAS:528:DyaL3cXks12itL4%3D 7373430
19. EP Alexandra 2006 Nanoscale characterization of the interface between bone and hydroxyapatite implants and the effect of silicon on bone apposition Micron 37 681 688 10.1016/j.micron.2006.03.006 (Pubitemid 44192607)
20. T Gao HT Aro H Ylänen E Vuorio 2001 Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro Biomaterials 22 1475 1483 10.1016/S0142-9612(00)00288-X 1:CAS:528:DC%2BD3MXktlGquro%3D 11374446 (Pubitemid 32573665)
21. DM Reffitt N Ogston R Jugdoahsingh HFJ Cheung BAJ Evans RPH Thompson JJ Powell GN Hampson 2003 Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro Bone 32 127 135 10.1016/S8756-3282(02)00950-X 1:CAS:528:DC%2BD3sXhvFWqu7s%3D 12633784 (Pubitemid 36299140)
22. MQ Arumugam DC Ireland RA Brooks N Rushton W Bonfield 2004 Orthosilicic acid increases collagen type I mRNA expression in human bone-derived osteoblasts in vitro Key Eng Mater 254 869 872 10.4028/www.scientific.net/KEM.254-256.869
23. S Ni J Chang L Chou W Zhai 2006 Comparison of osteoblast-like cell responses to calcium silicate and tricalcium phosphate ceramics in vitro J Biomed Mater Res 80B 174 183 10.1002/jbm.b.30582
24. N Patel SM Best W Bonfield 2002 A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules J Biomed Mater Res 69 1199 1206 (Pubitemid 36169459)
25. N Patel RA Brooks MT Clarke PMT Lee N Rushton IR Gibson SM Best W Bonfield 2005 In vivo assessment of hydroxyapatite and silicate-substituted hydroxyapatite granules using an ovine defect model J Biomed Mater Res 16 429 440 1:CAS:528:DC%2BD2MXjvVygsrw%3D
26. KA Hing PA Revell N Smith T Buckland 2006 Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds Biomaterials 27 5014 5026 10.1016/j.biomaterials.2006. 05.039 1:CAS:528:DC%2BD28Xmt1aiurw%3D 16790272 (Pubitemid 44202357)
27. AE Porter N Patel JN Skepper SM Best W Bonfield 2003 Comparison of in vivo dissolution processes in hydroxyapatite and silicon substituted hydroxyapatite bioceramics Biomaterials 24 4609 4620 10.1016/S0142-9612(03) 00355-7 1:CAS:528:DC%2BD3sXmvVams7s%3D 12951004 (Pubitemid 37013622)
28. CM Botelho MA Lopes IR Gibson SM Best JD Santos 2002 Structural analysis of Si-substituted hydroxyapatite: zeta potential and X-ray photoelectron spectroscopy J Mater Sci: Mater Med 13 1123 1127 10.1023/A:1021177601899 1:CAS:528:DC%2BD38XoslGmtr4%3D (Pubitemid 36172471)
29. F Balas J Perez-Pariente M Vallet-Regi 2003 In vivo bioactivity of silicon substituted hydroxyapatites J Biomed Mater Res 66A 364 375 10.1002/jbm.a.10579 1:CAS:528:DC%2BD3sXmtlyqs7o%3D
30. Popovic' D, Halloran JW, Hilmas GE, Brady GA, Somas S, Barda A, Zywicki G, Process for preparing textured ceramic composites, U.S. Patent 5645781.1997.
31. S Baskaran S Nunn D Popovic' JW Halloran 1993 Fibrous monolithic ceramics: I, fabrication, microstructure and indentation behavior J Am Ceram Soc 76 2209 2216 10.1111/j.1151-2916.1993.tb07756.x 1:CAS:528:DyaK3sXmslOgsr8%3D
32. 2 composites J Eur Ceram Soc 28 229 233 10.1016/j.jeurceramsoc.2007.05.010 1:CAS:528:DC%2BD2sXht1ajsrnF (Pubitemid 47629652)
33. G Mickisch S Fajta G Keilhauer E Schlick R Tschada P Alken 1990 Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT) Urol Res 18 131 136 10.1007/BF00302474 1:CAS:528:DyaK3cXktlChtbY%3D 1692648 (Pubitemid 20156760)
34. International standard 1999. Biological evaluation of medical devices. Part 5: Test for in vitro cytotoxicity. ISO-10993-5;1999 (E).
35. N Patel RA Brooks MT Clarke PMT Lee N Rushton IR Gibson SM Best W Bonfield 2005 In vivo assessment of hydroxyapatite and silicate-substituted granules using an ovine model J Mater Sci: Mater Med 16 429 440 10.1007/s10856-005-6983-6 1:CAS:528:DC%2BD2MXjvVygsrw%3D (Pubitemid 41217424)
36. M Hott B Noel D Bernache-Assolant C Rey PJ Marie 1997 Proliferation and differentiation of human trabecular osteoblastic cells on hydroxyapatite J Biomed Mater Res 37 508 516 10.1002/(SICI)1097-4636(19971215)37:4<508::AID- JBM9>3.0.CO;2-P 1:CAS:528:DyaK2sXns12ktLc%3D 9407299 (Pubitemid 27514858)
37. DP Pioletti J Muller LR Rakotomanana 2003 Effect of micromechanical stimulations on osteoblasts: development of a device simulating the mechanical situation at the bone-implant interface Biomechanics 36 131 135 10.1016/S0021-9290(02)00301-9 (Pubitemid 35448103)
38. A Nanci JD Wuest L Peru P Brunet V Sharma S Zalzal MD McKee 1998 Chemical modification of titanium surfaces for covalent attachment of biological molecules J Biomed Mater Res 40 324 335 10.1002/(SICI)1097-4636(199805)40: 2<324::AID-JBM18>3.0.CO;2-L 1:CAS:528:DyaK1cXhvVersrg%3D 9549628
39. K Webb V Hlady PA Tresco 2000 Relationships among cell attachment, spreading, cytoskeletal organization, and migration rate for anchorage-dependent cells on model surfaces J Biomed Mater Res 49 362 368 10.1002/(SICI)1097- 4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S 1:CAS:528:DC%2BD3cXltlGi 10602069 (Pubitemid 30030482)
40. M Bigerelle K Anselme E Dufresne 2002 An unscaled parameter to measure the order of surfaces: a new surface elaboration to increase cells adhesion Biomol Eng 19 79 83 10.1016/S1389-0344(02)00048-5 1:CAS:528:DC%2BD38XotFegs78%3D 12202166
41. L Xu KA Khor 2007 Chemical analysis of silica doped hydroxyapatite biomaterials consolidated by a spark plasma sintering method J Inorg Biochem 101 187 195 10.1016/j.jinorgbio.2006.09.030 1:CAS:528:DC%2BD2sXkvF2gtg%3D%3D 17095092 (Pubitemid 46084942)
42. R Rajaraman DE Rounds SPS Yen A Rembaum 1974 A scanning electron microscope study of cell adhesion and spreading in vitro Exp Cell Res 88 327 339 10.1016/0014-4827(74)90248-1 1:STN:280:DyaE2M%2FjvV2kuw%3D%3D 4426334
43. F Grinnell M Milam PA Srere 1973 Studies on cell adhesion. III. Adhesion of baby hamster kidney cells J Cell Biol 56 659 10.1083/jcb.56.3.659 1:CAS:528:DyaE3sXhtVKlsr0%3D 4734569
44. AC Taylor 1961 Attachment and spreading of cells in culture Exp Cell Res 8 154 173 10.1016/0014-4827(61)90346-9 13775553
45. D Lajeunesse C Frondoza B Schoffield B Sacktor 1990 Osteocalcin secretion by the human osteosarcoma cell line MG63 J Bone Miner Res 5 915 922 10.1002/jbmr.5650050904 1:CAS:528:DyaK3MXksVKmtLw%3D 2177953
46. V Kartsogiannis KW Ng 2004 Cell lines and primary cell cultures in the study of bone cell biology Mol Cell Endocrinol 228 79 102 10.1016/j.mce.2003.06. 002 1:CAS:528:DC%2BD2cXpslGms7w%3D 15541574 (Pubitemid 39482521)
47. ES Thian J Huang SM Best ZH Barber W Bonefield 2005 Magnetron co-sputtered silicon-containing hydroxyapatite thin films-an in vitro study Biomaterials 26 16 2947 2956 10.1016/j.biomaterials.2004.07.058 1:CAS:528:DC%2BD2cXhtVyrs7vF 15603789 (Pubitemid 39650941)
48. M Bohner 2009 Silicon-substituted calcium phosphates-a critical view Biomaterials 30 6403 6406 10.1016/j.biomaterials.2009.08.007 1:CAS:528:DC%2BD1MXhtFCktLzL 19695699
49. PP Deluca JA Schrier 1999 Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems Pharm Dev Technol 4 611 621 10.1081/PDT-100101400 10578516 (Pubitemid 29536083)
50. GC De la Piedra RT Jiménez 1990 Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers An Med Intern 7 534 538